Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

I. Kuter · SciRah

Researcher profile · Semantic Scholar

I. Kuter

Share profile

I. Kuter — researcher profile on SciRah

h-index: 25
Works: 55
Citations: 7,093

Most-cited papers

Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer.
J. Blum, S. Jones, A. Buzdar, P. LoRusso +6 more
1999Journal of Clinical Oncology793 citations
Semantic Scholar
Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab
Heloisa Sawaya, I. Sebag, J. Plana, J. Januzzi +13 more
2012Circulation Cardiovascular Imaging771 citations Open access
Semantic Scholar
Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma
J. Bendell, S. Domchek, Harold J. Burstein, L. Harris +6 more
2003Cancer727 citations
Semantic Scholar
Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients
Heloisa Sawaya, I. Sebag, J. Plana, J. Januzzi +12 more
2011American Journal of Cardiology691 citations Open access
Semantic Scholar
Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer: A Phase 1 Study
L. Emens, C. Cruz, J. Eder, F. Braiteh +15 more
2019JAMA Oncology687 citations Open access
Semantic Scholar
Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab
B. Ky, M. Putt, Heloisa Sawaya, B. French +14 more
2013Journal of the American College of Cardiology562 citations Open access
Semantic Scholar
Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer.
Eren D. Yeh, P. Slanetz, D. Kopans, E. Rafferty +6 more
2005AJR. American journal of roentgenology411 citations
Semantic Scholar
Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer.
H. Burstein, I. Kuter, S. Campos, R. Gelman +11 more
2001Journal of Clinical Oncology380 citations
Semantic Scholar
Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot study.
H. Burstein, L. Harris, R. Gelman, S. Lester +13 more
2003Journal of Clinical Oncology289 citations
Semantic Scholar
Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel.
A. Taghian, Sherif I. Assaad, A. Niemierko, I. Kuter +4 more
2001Journal of the National Cancer Institute194 citations
Semantic Scholar
Paclitaxel decreases the interstitial fluid pressure and improves oxygenation in breast cancers in patients treated with neoadjuvant chemotherapy: clinical implications.
A. Taghian, Rita Abi-Raad, Sherif I. Assaad, A. Casty +8 more
2005Journal of Clinical Oncology193 citations
Semantic Scholar
Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab
M. Putt, V. Hahn, J. Januzzi, Heloisa Sawaya +13 more
2015Clinical Chemistry179 citations Open access
Semantic Scholar
Survival in patients with brain metastases from breast cancer
A. Eichler, I. Kuter, P. Ryan, L. Schapira +2 more
2008Cancer160 citations
Semantic Scholar
VEGF as a Marker for Outcome Among Advanced Breast Cancer Patients Receiving anti-VEGF Therapy with Bevacizumab and Vinorelbine Chemotherapy
H. Burstein, Yu-Hui Chen, L. Parker, J. Savoie +10 more
2008Clinical Cancer Research136 citations Open access
Semantic Scholar
Major Cardiac Events and the Value of Echocardiographic Evaluation in Patients Receiving Anthracycline-Based Chemotherapy.
Lin Wang, T. Tan, E. Halpern, T. Neilan +8 more
2015American Journal of Cardiology103 citations
Semantic Scholar
Abstract 2986: Atezolizumab in metastatic TNBC (mTNBC): Long-term clinical outcomes and biomarker analyses
P. Schmid, C. Cruz, F. Braiteh, J. Eder +13 more
2017102 citations
Semantic Scholar
Dose-dependent change in biomarkers during neoadjuvant endocrine therapy with fulvestrant: results from NEWEST, a randomized Phase II study
I. Kuter, J. Gee, R. Hegg, C. Singer +9 more
2012Breast Cancer Research and Treatment99 citations
Semantic Scholar
Clinical Outcomes With Abemaciclib After Prior CDK4/6 Inhibitor Progression in Breast Cancer: A Multicenter Experience.
S. Wander, Hyo S. Han, Mark L. Zangardi, A. Niemierko +26 more
2021The Journal of the National Comprehensive Cancer Network84 citations Open access
Semantic Scholar
Flare response in 18F-fluoride ion PET bone scanning.
A. A. Wade, J. A. Scott, I. Kuter, A. Fischman
2006AJR. American journal of roentgenology76 citations
Semantic Scholar
A good drug made better: the fulvestrant dose-response story.
J. Robertson, J. Lindemann, S. Garnett, E. Anderson +3 more
2014Clinical Breast Cancer71 citations Open access
Semantic Scholar
Time Trends of Left Ventricular Ejection Fraction and Myocardial Deformation Indices in a Cohort of Women with Breast Cancer Treated with Anthracyclines, Taxanes, and Trastuzumab.
T. Tan, Souhila Bouras, Heloisa Sawaya, I. Sebag +5 more
2015Journal of the American Society of Echocardiography69 citations
Semantic Scholar
Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer.
H. Burstein, J. Bellon, S. Galper, Hsiao-Ming Lu +10 more
2006International Journal of Radiation Oncology, Biology, Physics60 citations
Semantic Scholar
A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer
S. Kuemmel, M. Campone, D. Loirat, R. López +24 more
2021Clinical Cancer Research42 citations Open access
Semantic Scholar
Development and Validation of a Gene Expression Score That Predicts Response to Fulvestrant in Breast Cancer Patients
S. Knudsen, T. Jensen, A. Hansen, W. Mazin +4 more
2014PLoS ONE32 citations Open access
Semantic Scholar
A multicenter analysis of abemaciclib after progression on palbociclib in patients (pts) with hormone receptor-positive (HR+)/HER2- metastatic breast cancer (MBC).
S. Wander, Mark L. Zangardi, A. Niemierko, A. Kambadakone +16 more
2019Journal of Clinical Oncology31 citations
Semantic Scholar
Personalized Medicine and Imaging Differences in the Transcriptional Response to Fulvestrant and Estrogen Deprivation in ER-Positive Breast Cancer
N. Patani, A. Dunbier, H. Anderson, Z. Ghazoui +11 more
201424 citations
Semantic Scholar
397 Preoperative trastuzumab and vinorelbine (HN) is a well-tolerated, active regimen for Her2 3+/FISH+stage II/III breast cancer
L. Harris, H. Burstein, R. Gelman, P. Freidman +6 more
200324 citations
Semantic Scholar
NEWEST: a Phase II, randomised, neoadjuvant trial comparing fulvestrant 500 mg vs 250 mg in postmenopausal women with locally advanced, oestrogen receptor-positive (ER+) breast cancer
C. Singer, I. Kuter, R. Hegg, R. Badwe +3 more
200816 citations
Semantic Scholar
Pilot study to assess prolonged overnight fasting in breast cancer survivors (longfast)
Elizabeth O’Donnell, Yael N. Shapiro, A. Comander, S. Isakoff +12 more
2022Breast Cancer Research and Treatment15 citations
Semantic Scholar
Long-term follow-up after preoperative trastuzumab and chemotherapy for HER2-overexpressing breast cancer.
E. Mayer, Adrienne B. Gropper, L. Harris, J. Gold +7 more
2015Clinical Breast Cancer15 citations
Semantic Scholar
Pharmacokinetic profile of fulvestrant 500 mg vs 250 mg: Results from the NEWEST study
I. Kuter, F. Sapunar, P. McCormack
200813 citations
Semantic Scholar
Immunologic quantitation of the carcinoma specific human carcinoma antigen in clinical samples
J. F. Codington, S. Haavik, N. Nikrui, I. Kuter +5 more
2002Cancer10 citations Open access
Semantic Scholar
Dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel (P) with trastuzumab (T) and lapatinib (L) in HER2/neu-positive breast cancer is not feasible due to excessive diarrhea: updated results.
C. Dang, N. Lin, B. Moy, S. Come +35 more
20098 citations
Semantic Scholar
Circulating Tumor Cells as Predictors of Response and Failure in Breast Cancer Patients Treated with Preoperative Chemotherapy
R. Boutrus, R. A. Raad, I. Kuter, M. Ancukiewicz +12 more
2013International Journal of Biological Markers7 citations Open access
Semantic Scholar
A Phase I Study of Adjuvant Niraparib Administered Concurrently with Postoperative Radiation Therapy in Patients with Localized Triple Negative Breast Cancer
J. Keenan, S. A. Dunn, M. Collins, A. Taghian +15 more
2022International Journal of Radiation Oncology, Biology, Physics6 citations
Semantic Scholar
2074 Increased risk of radiation pneumonitis in breast cancer patients treated by concomitant taxol and radiation therapy
A. Taghian, Sherif I. Assaad, I. Kuter, J. Younger +4 more
19996 citations
Semantic Scholar
Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer
Elyssa N Denault, E. Nakajima, V. Naranbhai, Jennifer A. Hutchinson +19 more
2022Therapeutic Advances in Medical Oncology5 citations Open access
Semantic Scholar
Adjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancer
S. McLaughlin, E. Nakajima, Yael Bar, Jennifer A. Hutchinson +6 more
2023Therapeutic Advances in Medical Oncology4 citations Open access
Semantic Scholar
358TiP Phase Ib/II study of antibody-drug conjugate, sacituzumab govitecan, in combination with the PARP inhibitor, talazoparib, in metastatic triple-negative breast cancer
A. Bardia, L. Spring, D. Juric, A. Partridge +14 more
20203 citations Open access
Semantic Scholar
Erratum: Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab (Journal of the American College of Cardiology (2014) 63 (809-816))
B. Ky, M. Putt, Heloisa Sawaya, B. French +14 more
20162 citations Open access
Semantic Scholar
Breast cancer.
I. Kuter
2001The Oncologist2 citations
Semantic Scholar
5080 Safety and tolerability of fulvestrant high-dose (500 mg) in postmenopausal women with hormone receptor positive advanced breast cancer
N. Gottschalk, I. Kuter, J. Robertson, M. Ellis +5 more
20091 citations
Semantic Scholar
Impact of Interstitial Fluid Pressure, Tumor Oxygenation, and Chemotherapy Drug Sequencing on Response to Neoadjuvant Chemotherapy and on Long-Term Local Control in Women Treated for Locally Advanced Breast Cancer
K. Hoffman, Rita Abi-Raad, M. Ancukiewicz, Eren D. Yeh +6 more
20071 citations
Semantic Scholar
Abstract P4-10-12: Abemaciclib monotherapy after disease progression on prior CDK4/6 inhibitors in patients with metastatic hormone-receptor positive breast cancer
S. Shahamatdar, K. Clifton, Julia Wu, A. Putur +10 more
2025Clinical Cancer Research0 citations
Semantic Scholar
Abstract 3360: Pre- and post-operative analysis of circulating tumor DNA in patients with breast cancer treated with neoadjuvant therapy using a tissue-free, methylation-based approach
A. Medford, Justine Knape, D. Dustin, Haiyang Zhang +10 more
2025Cancer Research0 citations
Semantic Scholar
Abstract PD5-11: Pilot study to assess prolonged nightly fasting in breast cancer survivors (LONGFAST)
Elizabeth O’Donnell, Yael N. Shapiro, Amy Comander, S. Isakoff +12 more
2022Cancer Research0 citations
Semantic Scholar
Abstract PS18-19: Comparison of metastatic genomic profile in patients ≤45 years and patients >45 years with triple-negative breast cancer
N. Vidula, A. Niemierko, Katherine Hesler, S. Isakoff +9 more
20210 citations
Semantic Scholar
109PCOMPARISON OF THE TRANSCRIPTIONAL RESPONSE TO FULVESTRANT AND OESTROGEN DEPRIVATION IN ER-POSITIVE BREAST CANCER IN VITRO AND IN VIVO
N. Patani, A. Dunbier, H. Anderson, E. Anderson +6 more
20130 citations Open access
Semantic Scholar
PMD6 Extracorporeal Photopheresis for the Treatment of Patients With Acute or Chronic Graft Versus Host Disease (GvHD), Refractory to Corticosteroids – A Sytematic Review
J. Walczak, K. Miernik, I. Kuter, M. Ussowicz
20120 citations Open access
Semantic Scholar
Abstract 19245: Time Trends of Echocardiography Measures of LV Function in a Cohort of Women with Breast Cancer Treated with Anthracyclines, Taxanes and Trastuzumab
T. Tan, Heloisa Sawaya, I. Sebag, V. Cohen +5 more
2012Circulation0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Younger×12
Invite
J. Younger — researcher profile on SciRah
B. Moy×11
Invite
B. Moy — researcher profile on SciRah
L. Spring×10
Invite
L. Spring — researcher profile on SciRah
A. Bardia×9
Invite
A. Bardia — researcher profile on SciRah

×8

Invite

M. Picard — researcher profile on SciRah

M. Scherrer-Crosbie×8

Invite

M. Scherrer-Crosbie — researcher profile on SciRah

Invite

S. Isakoff — researcher profile on SciRah

Heloisa Sawaya×7

Invite

Heloisa Sawaya — researcher profile on SciRah

Invite

I. Sebag — researcher profile on SciRah

Invite

V. Cohen — researcher profile on SciRah

Invite

E. Halpern — researcher profile on SciRah

Invite

J. Passeri — researcher profile on SciRah